FEB '20 Timm receives D-BSSE / Basel University Personalized Medicine funding scheme grant

‘Patient specific signalling dynamics in myeloproliferative neoplasms as predictive biomarkers for outcome and responsiveness to treatment’ with Skoda group from Basel University.